These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11585673)

  • 1. Molecular genetic analysis of diabetes in mice.
    Gannon M
    Trends Genet; 2001 Oct; 17(10):S23-8. PubMed ID: 11585673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.
    Planas R; Alba A; Carrillo J; Puertas MC; Ampudia R; Pastor X; Okamoto H; Takasawa S; Gurr W; Pujol-Borrell R; Verdaguer J; Vives-Pi M
    Diabetologia; 2006 Oct; 49(10):2379-87. PubMed ID: 16900387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diabetes: is GAD the culprit?
    Lopez-Liuchi JV
    Eur J Endocrinol; 1999 Nov; 141(5):458-9. PubMed ID: 10576760
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic manipulation of insulin action and beta-cell function in mice.
    Lamothe B; Duvillié B; Cordonnier N; Baudry A; Saint-Just S; Bucchini D; Jami J; Joshi RL
    Mol Cell Biochem; 1998 May; 182(1-2):161-8. PubMed ID: 9609125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized mice for the study of type 1 and type 2 diabetes.
    Greiner DL; Brehm MA; Hosur V; Harlan DM; Powers AC; Shultz LD
    Ann N Y Acad Sci; 2011 Dec; 1245():55-8. PubMed ID: 22211980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
    Luo X; Yang H; Kim IS; Saint-Hilaire F; Thomas DA; De BP; Ozkaynak E; Muthukumar T; Hancock WW; Crystal RG; Suthanthiran M
    Transplantation; 2005 May; 79(9):1091-6. PubMed ID: 15880049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
    Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
    J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice.
    Gurr W; Yavari R; Wen L; Shaw M; Mora C; Christa L; Sherwin RS
    Diabetes; 2002 Feb; 51(2):339-46. PubMed ID: 11812740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
    Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
    Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NOD mouse (non-obese diabetic mouse)].
    Moriyama H; Nagata M; Yokono K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():688-94. PubMed ID: 9513497
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gene therapy for diabetes].
    Moritani M; Itakura M
    Nihon Rinsho; 1997 Nov; 55 Suppl():739-45. PubMed ID: 9434557
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.
    Moriyama H; Abiru N; Paronen J; Sikora K; Liu E; Miao D; Devendra D; Beilke J; Gianani R; Gill RG; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10376-81. PubMed ID: 12925730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NOD mouse.
    Hanafusa T; Miyagawa J; Nakajima H; Tomita K; Kuwajima M; Matsuzawa Y; Tarui S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S307-11. PubMed ID: 7859625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenes and knockout mutations in animal models of type 1 diabetes and multiple sclerosis.
    Wong FS; Dittel BN; Janeway CA
    Immunol Rev; 1999 Jun; 169():93-104. PubMed ID: 10450511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta cell apoptosis in T cell-mediated autoimmune diabetes.
    Kurrer MO; Pakala SV; Hanson HL; Katz JD
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):213-8. PubMed ID: 8990188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in midlife: planting genetic time bombs.
    O'Rahilly S
    Nat Med; 1997 Oct; 3(10):1080-1. PubMed ID: 9334713
    [No Abstract]   [Full Text] [Related]  

  • 19. An HLA-Transgenic Mouse Model of Type 1 Diabetes That Incorporates the Reduced but Not Abolished Thymic Insulin Expression Seen in Patients.
    Babad J; Ali R; Schloss J; DiLorenzo TP
    J Diabetes Res; 2016; 2016():7959060. PubMed ID: 26824049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signal for beta-cell failure.
    Avruch J
    Nature; 1998 Feb; 391(6670):846-7. PubMed ID: 9495335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.